Dow Up0.76% Nasdaq Up0.69%

Celldex Therapeutics, Inc. (CLDX)

-NasdaqGS
15.50 Up 0.09(0.58%) Oct 24, 4:00PM EDT
|After Hours : 15.60 Up 0.10 (0.65%) Oct 24, 5:16PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 592   416   620   980  
Cost of Revenue -   -   -   -  
Gross Profit 592   416   620   980  
Operating Expenses
Research Development24,099  27,070  17,804  20,417  
Selling General and Administrative4,787  4,582  4,677  3,579  
Non Recurring -   -   -   -  
Others254  253  253  253  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (28,548) (31,489) (22,114) (23,269)
Income from Continuing Operations
Total Other Income/Expenses Net274  1,586  137  142  
Earnings Before Interest And Taxes(28,274)(29,903)(21,977)(23,127)
Interest Expense -   -  85  13  
Income Before Tax(28,274)(29,903)(22,062)(23,140)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(28,274)(29,903)(22,062)(23,140)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (28,274) (29,903) (22,062) (23,140)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (28,274) (29,903) (22,062) (23,140)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.